Trastuzumab duocarmazine (Synonyms: (vic)-Trastuzumab duocarmazine) |
| Catalog No.GC26478 |
Trastuzumab duocarmazine ((vic) - Trastuzumab duocarmazine) is a HER2 targeted ADC that can be recognized and cleaved by tissue protease B in tumor cells, selectively targeting tumor cells.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1642152-40-6
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Trastuzumab duocarmazine ((vic) - Trastuzumab duocarmazine) is a HER2 targeted ADC that can be recognized and cleaved by tissue protease B in tumor cells, selectively targeting tumor cells. Trastuzumab duocarmazine has anti-tumor activity and can be used for research on related cancers such as uterine and ovarian carcinosarcoma.
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *